ArticleJournal of the American Association for Laboratory Animal Science : JAALAS2025
Comparison of Dexmedetomidine/Morphine and Xylazine/Morphine as Premedication in Isoflurane-Anesthetized Sheep.
Article in Journal of the American Association for Laboratory Animal Science : JAALAS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Discovery, Structural Characterization, and Preclinical Evaluation of Monoclonal Antibodies against Xylazine Poisoning.ACS pharmacology & translational science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study we investigated the sedative, anesthetic, and pulmonary histopathologic effects of dexmedetomidine/morphine (DM) and xylazine/morphine (XM) in sheep. We hypothesized that DM would provide profound sedation and better maintain physiologic parameters under anesthesia than XM in sheep undergoing laparoscopic surgery. Nineteen male sheep were premedicated with either DM (dexmedetomidine [0.006 mg/kg] and morphine [0.3 mg/kg]) or XM (xylazine [0.1 mg/kg] and morphine [0.3 mg/kg]). After DM or XM administration, 3 blinded veterinarians evaluated sedation scores (0 [no sedation], 1 [mild], 2 [moderate], 3 [severe]). Sheep were induced with intravenous tiletamine/zolazepam, intubated, and maintained with isoflurane in 100% oxygen. Anesthetic parameters were monitored for 60 min, including heart rate, respiratory rate, indirect blood pressure, oxygen saturation, end-tidal carbon dioxide, body temperature, arterial blood gas analysis, and isoflurane requirement. At the end of the procedure, the sheep were euthanized, and lung pathology (pulmonary edema) was assessed. The results showed that the sedation scores did not differ between DM (0.8 [0.4 to 1.0]) and XM (1.0 [1.0 to 1.0]). In addition, the anesthetic parameters were comparable between the groups, but the DM group exhibited a higher heart rate than the XM group. Finally, marked pulmonary changes, consistent with pulmonary edema, were observed in the XM group. In conclusion, DM and XM provided similar sedation and physiologic stability under isoflurane anesthesia, but DM may help minimize bradycardia and was associated with less evidence of pulmonary edema.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.